The company is currently working on late-stage trials for three potentially groundbreaking new drugs. CRBP stock has continued to bounce on the potential of these new drugs being approved for sale in the U.S. But, as we know it is extremely difficult to get through this approval process. Regardless, the cannabis stock to watch has made approval its end goal with these drugs on their way to the last stage of testing. Because of this, it seems as though Corbus could continue to be viewed as a marijuana stock to watch.